1832 Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,529
Closed -$272K – 901
2022
Q1
$272K Buy
+4,529
New +$270K ﹤0.01% 695
2021
Q2
– Sell
-10,212
Closed -$561K – 750
2021
Q1
$561K Sell
10,212
-108
-1% -$5.99K ﹤0.01% 473
2020
Q4
$560K Buy
10,320
+1,794
+21% +$93.8K ﹤0.01% 529
2020
Q3
$422K Hold
8,526
– – ﹤0.01% 518
2020
Q2
$370K Sell
8,526
-3,906
-31% -$167K ﹤0.01% 496
2020
Q1
$474K Sell
12,432
-2,400
-16% -$101K ﹤0.01% 515
2019
Q4
$655K Hold
14,832
– – ﹤0.01% 458
2019
Q3
$603K Hold
14,832
– – ﹤0.01% 455
2019
Q2
$591K Sell
14,832
-7,242
-33% -$274K ﹤0.01% 487
2019
Q1
$846K Buy
+22,074
New +$801K ﹤0.01% 395
2018
Q4
– Sell
-50,280
Closed -$1.91M – 676
2018
Q3
$1.91M Hold
50,280
– – 0.01% 397
2018
Q2
$1.68M Sell
50,280
-5,052
-9% -$165K 0.01% 393
2018
Q1
$1.71M Sell
55,332
-5,034
-8% -$155K 0.01% 384
2017
Q4
$1.74M Buy
+60,366
New +$1.74M 0.01% 383

Other funds holding IHI

1832 Asset Management's IHI Position: Q2 2022 in Review

1832 Asset Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2022, closing a stake of 4,529 shares — an estimated $272K sold.

1832 Asset Management first reported a position in IHI in Q4 2017 and held it in 14 quarters. The position peaked at $1.91M in Q3 2018. 592 funds tracked by Wall St. Rank hold IHI as of Q2 2022.

  • 1832 Asset Management reported no remaining iShares US Medical Devices ETF position as of Q2 2022 after selling out during the quarter.
  • 1832 Asset Management sold 4,529 iShares US Medical Devices ETF shares in Q2 2022, an estimated $272K.
  • 1832 Asset Management first reported a position in iShares US Medical Devices ETF in Q4 2017 and held it in 14 quarters.
  • 1832 Asset Management's iShares US Medical Devices ETF position peaked at $1.91M in Q3 2018.
  • 592 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2022.

Based on 1832 Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.